Home
Contact Us
About Us
Advertise
Biotech
Finance
Tech News
Disclaimer
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
BioPharmaJournal
Home
Contact Us
About Us
Advertise
Biotech
Chimerix Inc (NASDAQ: CMRX) Receives $25.3 Million Procurement Contract For TEMBEXA
Regulus Therapeutics Inc (NASDAQ: RGLS) Pleased after FDA Approved its Orphan…
Ocugen Inc (NASDAQ: OCGN) Announces the Successful Publication of Positive Outcomes…
Brickell Biotech Inc (NASDAQ: BBI) Announces Dosing of First Subject with…
Cronos Group Inc (NASDAQ: CRON) and Ginkgo Bioworks Holdings Inc (NYSE:…
Finance
Why Your Body Needs Nitric Oxide Boost Beets For More Energy…
Top Beer Stocks for the Recession-Proof Portfolio (BUD, KEGS, SAM, TAP,…
Cutting Edge Power announces an all-new version of its popular Smart…
Lucid Group Inc (NASDAQ:LCID) Poised for Action as New Catalysts Mount
Galera Therapeutics Inc. (NASDAQ: GRTX) Announced Updated Findings Of Phase 3…
Tech News
Aehr Test Systems (NASDAQ: AEHR) Receives an Order of $10.8 Million…
Tauriga Sciences Inc (OTCMKTS:TAUG) Could React on New Aegea Rapid Test…
Micro and Macro Tailwinds Converge for KULR
ISWH and the Rebirth of the Crypto Cycle
Disclaimer
Home
Tags
NASDAQ:HEPA
Tag: NASDAQ:HEPA
Hepion Pharmaceuticals Inc. (NASDAQ:HEPA) Announces Dosing Of First NASH Patient With...
admin
-
January 11, 2021
0
Hepion Pharmaceuticals Inc. (NASDAQ:HEPA) Announces CRV431 Study Results In Liver Disease
Gavins Felicity
-
December 17, 2020
0
Hepion Pharmaceuticals Inc (NASDAQ:HEPA) Completes The Study Of CRV431
Matt Wade
-
September 11, 2020
0
Hepion Pharmaceuticals Inc (NASDAQ:HEPA) Releases Early Stage Data For CRV431’s Research...
Ward Sport
-
July 17, 2020
0
Recent Post
Chimerix Inc (NASDAQ: CMRX) Receives $25.3 Million Procurement Contract For TEMBEXA
Kate Hudson
-
July 4, 2022
0
Chimerix Inc (NASDAQ: CMRX) has received a $25.3 million contract agreement from the Public Health Agency of Canada for the procurement of TEMBEX (brincidofovir)....
Regulus Therapeutics Inc (NASDAQ: RGLS) Pleased after FDA Approved its Orphan...
July 1, 2022
Cannabis Stocks Deeply Oversold with Big Growth Ahead (TLRY, SGMD, OGI,...
June 30, 2022
Ocugen Inc (NASDAQ: OCGN) Announces the Successful Publication of Positive Outcomes...
June 30, 2022
Why Your Body Needs Nitric Oxide Boost Beets For More Energy...
June 28, 2022